Why BioNTech Leaped Nearly 7% Higher Today
Model coronavirus stock BioNTech (NASDAQ: BNTX) shot 6.6% higher Friday. This was due to encouraging news about the coronavirus vaccine BNT162b2, which it developed with Pfizer (NYSE: PFE). A big pronouncement by a major health authority also helped.
In a 175-participant study of elderly patients who had received both doses of the two-jab BNT162b2, British researchers found that it actually induces a stronger antibody response when the two shots are spaced further apart than recommended -- 12 weeks rather than the three of official guidance.
Image source: Getty Images.
Source Fool.com


_0.png?locale=de)